Notice Pursuant to the National Cooperative Research and Production Act of 1993-Subcutaneous Drug Development & Delivery Consortium, Inc., 2182 [2022-00591]

Download as PDF jspears on DSK121TN23PROD with NOTICES1 2182 Federal Register / Vol. 87, No. 9 / Thursday, January 13, 2022 / Notices Midland, TX; Ventum Consulting Foshan Ltd, Beijing, PEOPLE’S REPUBLIC OF CHINA; ViaSat, Inc., Carlsbad, CA; and wehyve GmbH, Braunschweig, GERMANY, have been added as parties to this venture. Also, ASE Consulting, Ltd., Lytham, UNITED KINGDOM; Avanade, Inc., Seattle, WA; Beijing JCC Information Consulting Co., Ltd, Beijing, PEOPLE’S REPUBLIC OF CHINA; Beijing Thunisoft Information Technology Co., Ltd., Beijing, PEOPLE’S REPUBLIC OF CHINA, BMC Software, Inc., Houston, TX; Bridewell Consulting Ltd, Reading, UNITED KINGDOM; Cisco Systems, Inc., San Jose, CA; Ecole Centrale de Lille, Villeneuve d’Ascq, FRANCE; Edgelox, Duluth, GA; Embassy of Things, San Diego, CA; Envizion cvba, Boutersem, BELGIUM; Fruition Partners B.V., Rijswijk, THE NETHERLANDS; Gelder Gringas and Associates, Ottawa, CANADA; Hint Americas, Inc., Houston, TX; Interface Concept Inc., Naperville, IL; Johns Hopkins University Applied Physics Laboratory, Laurel, MD; Leeds City Council, Leeds, UNITED KINGDOM; Lyrn, Copenhagen, DENMARK; Maana, Inc., Menlo Park, CA; Mellanox Federal Systems, Houston, TX; Mundo Cognito Ltd., Penn, UNITED KINGDOM; Noble Energy, Inc., Houston, TX; OPC Foundation, Ravenna, OH; Panamerica Computers, Inc., dba PCi Tec, Luray, VA; PMK Architecture Services, LLC, San Diego, CA; RagnaRock Geo, Trondheim, NORWAY; Searcher Seismic Geodata Pty Ltd, West Perth, AUSTRALIA; SMART Embedded Computing, Tempe, AZ; TRM Technologies Inc., Ottawa, CANADA; University of York, Department of Computer Science, York, UNITED KINGDOM; and vCISO Services, LLC, Franklin, TN, have withdrawn as parties to this venture. In addition, Wintershall DEA GmbH has changed its name to Wintershall DEA AG, Hamburg, Germany. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and TOG intends to file additional written notifications disclosing all changes in membership. On April 21, 1997, TOG filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on June 13, 1997 (62 FR 32371). The last notification was filed with the Department on August 2, 2021. A notice was published in the Federal VerDate Sep<11>2014 18:18 Jan 12, 2022 Jkt 256001 Register pursuant to Section 6(b) of the Act on August 23, 2021 (86 FR 47148). Register pursuant to Section 6(b) of the Act on April 15, 2021 (86 FR 19902). Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division. Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division. [FR Doc. 2022–00590 Filed 1–12–22; 8:45 am] [FR Doc. 2022–00591 Filed 1–12–22; 8:45 am] BILLING CODE 4410–11–P BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Antitrust Division Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Subcutaneous Drug Development & Delivery Consortium, Inc. Notice Pursuant to the National Cooperative Research and Production Act of 1993—Electrified Vehicle and Energy Storage Evaluation Notice is hereby given that, on December 8, 2021, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Subcutaneous Drug Development & Delivery Consortium, Inc., (‘‘Subcutaneous Drug Development & Delivery Consortium, Inc.’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, GlaxoSmithKline LLC, Collegeville, PA; Merck Sharp & Dohme Corp, Kenilworth, NJ; and Pfizer Inc., New York, NY, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Subcutaneous Drug Development & Delivery Consortium, Inc. intends to file additional written notifications disclosing all changes in membership. On October 26, 2020, Subcutaneous Drug Development & Delivery Consortium, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on December 3, 2020 (85 FR 78148). The last notification was filed with the Department on March 31, 2021. A notice was published in the Federal PO 00000 Frm 00057 Fmt 4703 Sfmt 9990 Notice is hereby given that, on December 21, 2021, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Electrified Vehicle and Energy Storage Evaluation (‘‘EVESE’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Brunswick, Mettawa, IL, has been added as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and EVESE intends to file additional written notifications disclosing all changes in membership. On September 24, 2020, EVESE filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on October 15, 2020 (85 FR 65423). The last notification was filed with the Department on September 21, 2021. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on October 25, 2021 (86 FR 58691). Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division. [FR Doc. 2022–00605 Filed 1–12–22; 8:45 am] BILLING CODE 4410–11–P E:\FR\FM\13JAN1.SGM 13JAN1

Agencies

[Federal Register Volume 87, Number 9 (Thursday, January 13, 2022)]
[Notices]
[Page 2182]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00591]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Subcutaneous Drug Development & Delivery 
Consortium, Inc.

    Notice is hereby given that, on December 8, 2021, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Subcutaneous Drug 
Development & Delivery Consortium, Inc., (``Subcutaneous Drug 
Development & Delivery Consortium, Inc.'') has filed written 
notifications simultaneously with the Attorney General and the Federal 
Trade Commission disclosing changes in its membership. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Specifically, GlaxoSmithKline 
LLC, Collegeville, PA; Merck Sharp & Dohme Corp, Kenilworth, NJ; and 
Pfizer Inc., New York, NY, have been added as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and Subcutaneous Drug Development & 
Delivery Consortium, Inc. intends to file additional written 
notifications disclosing all changes in membership.
    On October 26, 2020, Subcutaneous Drug Development & Delivery 
Consortium, Inc. filed its original notification pursuant to Section 
6(a) of the Act. The Department of Justice published a notice in the 
Federal Register pursuant to Section 6(b) of the Act on December 3, 
2020 (85 FR 78148).
    The last notification was filed with the Department on March 31, 
2021. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on April 15, 2021 (86 FR 19902).

Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2022-00591 Filed 1-12-22; 8:45 am]
BILLING CODE 4410-11-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.